Skip to main content

Abstract

Historically, the overall 5-year survival probability from lung cancer is dismal. However, this poor prognosis is not uniformly distributed among those affected—certain subsets of patients appear to fare worse, either due to a more advanced stage at presentation or barriers to appropriate and timely care. Disparities in lung cancer development, diagnosis, treatment, and outcomes are predominantly seen in members of racial, ethnic, and other minority groups, women, HIV patients, and the elderly. The basis for such differences is complex and multifactorial, involving social inequities overlapping with genetic and biologic factors. For this reason, improvement in lung cancer survival can only occur when these disparities are addressed and corrected.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Williams DR, et al. Integrating multiple social statuses in health disparities research: the case of lung cancer. Health Serv Res. 2012;47:1255–77. doi:10.1111/j.1475-6773.2012.01404.x.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Unequal treatment: confronting racial and ethnic disparities in health care (full printed version). Washington, DC: The National Academies Press; 2003.

    Google Scholar 

  3. Forrest LF, Adams J, Wareham H, Rubin G, White M. Socioeconomic inequalities in lung cancer treatment: systematic review and meta-analysis. PLoS Med. 2013;10:e1001376. doi:10.1371/journal.pmed.1001376.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Erhunmwunsee L, Joshi MB, Conlon DH, Harpole Jr DH. Neighborhood-level socioeconomic determinants impact outcomes in nonsmall cell lung cancer patients in the Southeastern United States. Cancer. 2012;118:5117–23. doi:10.1002/cncr.26185.

    Article  PubMed  Google Scholar 

  5. Herd P, Goesling B, House JS. Socioeconomic position and health: the differential effects of education versus income on the onset versus progression of health problems. J Health Soc Behav. 2007;48:223–38.

    Article  PubMed  Google Scholar 

  6. Yang R, et al. Do racial or socioeconomic disparities exist in lung cancer treatment? Cancer. 2010;116:2437–47. doi:10.1002/cncr.24986.

    PubMed  Google Scholar 

  7. Williams DR, Collins C. Racial residential segregation: a fundamental cause of racial disparities in health. Public Health Rep. 2001;116:404–16.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Williams DR, Mohammed SA, Leavell J, Collins C. Race, socioeconomic status, and health: complexities, ongoing challenges, and research opportunities. Ann N Y Acad Sci. 2010;1186:69–101. doi:10.1111/j.1749-6632.2009.05339.x.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Ward E, et al. Cancer disparities by race/ethnicity and socioeconomic status. CA Cancer J Clin. 2004;54:78–93.

    Article  PubMed  Google Scholar 

  10. Potosky AL, Saxman S, Wallace RB, Lynch CF. Population variations in the initial treatment of non-small-cell lung cancer. J Clin Oncol. 2004;22:3261–8. doi:10.1200/JCO.2004.02.051.

    Article  PubMed  Google Scholar 

  11. Bach PB, Cramer LD, Warren JL, Begg CB. Racial differences in the treatment of early-stage lung cancer. N Engl J Med. 1999;341:1198–205. doi:10.1056/NEJM199910143411606.

    Article  CAS  PubMed  Google Scholar 

  12. Haiman CA, et al. Ethnic and racial differences in the smoking-related risk of lung cancer. N Engl J Med. 2006;354:333–42. doi:10.1056/NEJMoa033250.

    Article  CAS  PubMed  Google Scholar 

  13. Kagawa-Singer M, Dadia AV, Yu MC, Surbone A. Cancer, culture, and health disparities: time to chart a new course? CA Cancer J Clin. 2010;60:12–39. doi:10.3322/caac.20051.

    Article  PubMed  Google Scholar 

  14. Margolis ML, et al. Racial differences pertaining to a belief about lung cancer surgery: results of a multicenter survey. Ann Intern Med. 2003;139:558–63.

    Article  PubMed  Google Scholar 

  15. Gordon HS, Street Jr RL, Sharf BF, Kelly PA, Souchek J. Racial differences in trust and lung cancer patients’ perceptions of physician communication. J Clin Oncol. 2006;24:904–9. doi:10.1200/JCO.2005.03.1955.

    Article  PubMed  Google Scholar 

  16. Mulligan CR, et al. Unlimited access to care: effect on racial disparity and prognostic factors in lung cancer. Cancer Epidemiol Biomarkers Prev. 2006;15:25–31. doi:10.1158/1055-9965.EPI-05-0537.

    Article  PubMed  Google Scholar 

  17. Farjah F, et al. Racial disparities among patients with lung cancer who were recommended operative therapy. Arch Surg. 2009;144:14–8. doi:10.1001/archsurg.2008.519.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Hardy D, et al. Racial disparities and survival for nonsmall-cell lung cancer in a large cohort of black and white elderly patients. Cancer. 2009;115:4807–18. doi:10.1002/cncr.24521.

    Article  PubMed  Google Scholar 

  19. Lathan CS, Neville BA, Earle CC. The effect of race on invasive staging and surgery in non-small-cell lung cancer. J Clin Oncol. 2006;24:413–8. doi:10.1200/JCO.2005.02.1758.

    Article  PubMed  Google Scholar 

  20. Bryant AS, Cerfolio RJ. Impact of race on outcomes of patients with non-small cell lung cancer. J Thorac Oncol. 2008;3:711–5. doi:10.1097/JTO.0b013e31817c60c7.

    Article  PubMed  Google Scholar 

  21. Berger M, Lund M, Brawley O. Racial disparities in lung cancer. Curr Probl Cancer. 2007;31:202–10. doi:10.1016/j.currproblcancer.2007.02.002.

    Article  PubMed  Google Scholar 

  22. Hede K. Drilling down to the causes of racial disparities in lung cancer. J Natl Cancer Inst. 2010;102:1385–7. doi:10.1093/jnci/djq371.

    Article  PubMed  Google Scholar 

  23. Park ER, Japuntich SJ, Traeger L, Cannon S, Pajolek H. Disparities between blacks and whites in tobacco and lung cancer treatment. Oncologist. 2011;16:1428–34. doi:10.1634/theoncologist.2011-0114.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Whooley MA, Boyd AL, Gardin JM, Williams DR. Religious involvement and cigarette smoking in young adults: the CARDIA study (Coronary Artery Risk Development in Young Adults)study. Arch Intern Med. 2002;162:1604–10.

    Article  PubMed  Google Scholar 

  25. Wallace Jr JM, Brown TN, Bachman JG, LaVeist TA. The influence of race and religion on abstinence from alcohol, cigarettes and marijuana among adolescents. J Stud Alcohol. 2003;64:843–8.

    Article  PubMed  Google Scholar 

  26. Dey AN, Lucas JW. Physical and mental health characteristics of U.S.- and foreign-born adults: United States, 1998-2003. Advance Data; 2006. p. 1–19.

    Google Scholar 

  27. Singh GK, Miller BA. Health, life expectancy, and mortality patterns among immigrant populations in the United States. Can J Public Health. 2004;95:I14–21.

    PubMed  Google Scholar 

  28. Clegg LX, et al. Impact of socioeconomic status on cancer incidence and stage at diagnosis: selected findings from the surveillance, epidemiology, and end results: National Longitudinal Mortality Study. Cancer Causes Control. 2009;20:417–35. doi:10.1007/s10552-008-9256-0.

    Article  PubMed  Google Scholar 

  29. Lin JJ, Mhango G, Wall MM, Lurslurchachai L, Bond KT, Nelson JE, Berman AR, Salazar-Schicchi J, Powell C, Keller SM, Halm EA, Leventhal H, Wisnivesky JP. Cultural factors associated with racial disparities in lung cancer care. Ann Am Thorac Soc. 2014;11:489–95. doi:10.1513/AnnalsATS.201402-055OC.

    Article  PubMed  Google Scholar 

  30. Suga JM, et al. Racial disparities on the use of invasive and noninvasive staging in patients with non-small cell lung cancer. J Thorac Oncol. 2010;5:1772–8. doi:10.1097/JTO.0b013e3181f69f22.

    Article  PubMed  Google Scholar 

  31. McCann J, et al. Evaluation of the causes for racial disparity in surgical treatment of early stage lung cancer. Chest. 2005;128:3440–6. doi:10.1378/chest.128.5.3440.

    Article  PubMed  Google Scholar 

  32. Mehta RS, Lenzner D, Argiris A. Race and health disparities in patient refusal of surgery for early-stage non-small cell lung cancer: a SEER cohort study. Ann Surg Oncol. 2012;19:722–7. doi:10.1245/s10434-011-2087-3.

    Article  PubMed  Google Scholar 

  33. Cykert S, et al. Factors associated with decisions to undergo surgery among patients with newly diagnosed early-stage lung cancer. JAMA. 2010;303:2368–76. doi:10.1001/jama.2010.793.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Persky S, Kaphingst KA, Allen Jr VC, Senay I. Effects of patient-provider race concordance and smoking status on lung cancer risk perception accuracy among African-Americans. Ann Behav Med. 2013;45:308–17. doi:10.1007/s12160-013-9475-9.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Hardy D, Chan W, Liu C, Cormier J, Xia R, Bruera E, Du X. Racial disparities in the use of hospice services according to geographic residence and socioeconomic status in an elderly cohort with nonsmall cell lung cancer. Cancer. 2011;117:1506–15. doi:10.1002/cncr.25669.

    Article  PubMed  Google Scholar 

  36. U.S. Census Bureau. Current population reports consumer income P60. Washington, DC: Bureau of the Census. 2009

    Google Scholar 

  37. Wilper AP, et al. Health insurance and mortality in US adults. Am J Public Health. 2009;99:2289–95. doi:10.2105/AJPH.2008.157685.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Slatore CG, Au DH, Gould MK, American Thoracic Society Disparities in Healthcare Group. An official American Thoracic Society systematic review: insurance status and disparities in lung cancer practices and outcomes. Am J Respir Crit Care Med. 2010;182:1195–205. doi:10.1164/rccm.2009-038ST.

    Article  PubMed  Google Scholar 

  39. Virgo KS, et al. Safety-net burden hospitals and likelihood of curative-intent surgery for non-small cell lung cancer. J Am Coll Surg. 2011;213:633–43. doi:10.1016/j.jamcollsurg.2011.07.014.

    Article  PubMed  Google Scholar 

  40. Bradley CJ, Given CW, Roberts C. Disparities in cancer diagnosis and survival. Cancer. 2001;91:178–88.

    Article  CAS  PubMed  Google Scholar 

  41. Bradley CJ, Given CW, Dahman B, Luo Z, Virnig BA. Diagnosis of advanced cancer among elderly Medicare and Medicaid patients. Med Care. 2007;45:410–9. doi:10.1097/01.mlr.0000256970.19359.2a.

    Article  PubMed  Google Scholar 

  42. Bradley CJ, Gardiner J, Given CW, Roberts C. Cancer, Medicaid enrollment, and survival disparities. Cancer. 2005;103:1712–8. doi:10.1002/cncr.20954.

    Article  PubMed  Google Scholar 

  43. Bradley CJ, Dahman B, Given CW. Treatment and survival differences in older Medicare patients with lung cancer as compared with those who are dually eligible for Medicare and Medicaid. J Clin Oncol. 2008;26:5067–73. doi:10.1200/JCO.2008.16.3071.

    Article  PubMed  PubMed Central  Google Scholar 

  44. Shugarman LR, Sorbero ME, Tian H, Jain AK, Ashwood JS. An exploration of urban and rural differences in lung cancer survival among medicare beneficiaries. Am J Public Health. 2008;98:1280–7. doi:10.2105/AJPH.2006.099416.

    Article  PubMed  PubMed Central  Google Scholar 

  45. Cheung MC, et al. Impact of teaching facility status and high-volume centers on outcomes for lung cancer resection: an examination of 13,469 surgical patients. Ann Surg Oncol. 2009;16:3–13. doi:10.1245/s10434-008-0025-9.

    Article  PubMed  Google Scholar 

  46. Roetzheim RG, et al. Managed care and cancer outcomes for Medicare beneficiaries with disabilities. Am J Manag Care. 2008;14:287–96.

    PubMed  PubMed Central  Google Scholar 

  47. Greenberg ER, et al. Social and economic factors in the choice of lung cancer treatment. A population-based study in two rural states. N Engl J Med. 1988;318:612–7. doi:10.1056/NEJM198803103181006.

    Article  CAS  PubMed  Google Scholar 

  48. Esnaola NF, et al. Underuse of surgical resection for localized, non-small cell lung cancer among whites and African Americans in South Carolina. Ann Thorac Surg. 2008;86:220–6; discussion 227. doi:10.1016/j.athoracsur.2008.02.072.

    Google Scholar 

  49. Harlan LC, et al. Insurance status and the use of guideline therapy in the treatment of selected cancers. J Clin Oncol. 2005;23:9079–88. doi:10.1200/JCO.2004.00.1297.

    Article  PubMed  Google Scholar 

  50. Groth SS, et al. Effect of insurance status on the surgical treatment of early-stage non-small cell lung cancer. Ann Thorac Surg. 2013;95:1221–6. doi:10.1016/j.athoracsur.2012.10.079.

    Article  PubMed  Google Scholar 

  51. Yorio JT, Yan J, Xie Y, Gerber DE. Socioeconomic disparities in lung cancer treatment and outcomes persist within a single academic medical center. Clin Lung Cancer. 2012;13:448–57. doi:10.1016/j.cllc.2012.03.002.

    Article  PubMed  PubMed Central  Google Scholar 

  52. Lathan CS, Neville BA, Earle CC. Racial composition of hospitals: effects on surgery for early-stage non-small-cell lung cancer. J Clin Oncol. 2008;26:4347–52. doi:10.1200/JCO.2007.15.5291.

    Article  PubMed  PubMed Central  Google Scholar 

  53. Bach PB, et al. The influence of hospital volume on survival after resection for lung cancer. N Engl J Med. 2001;345:181–8. doi:10.1056/NEJM200107193450306.

    Article  CAS  PubMed  Google Scholar 

  54. Goodney PP, Lucas FL, Stukel TA, Birkmeyer JD. Surgeon specialty and operative mortality with lung resection. Ann Surg. 2005;241:179–84.

    PubMed  PubMed Central  Google Scholar 

  55. Neighbors CJ, et al. Ethnic/racial disparities in hospital procedure volume for lung resection for lung cancer. Med Care. 2007;45:655–63. doi:10.1097/MLR.0b013e3180326110.

    Article  PubMed  Google Scholar 

  56. Paggi MG, Vona R, Abbruzzese C, Malorni W. Gender-related disparities in non-small cell lung cancer. Cancer Lett. 2010;298:1–8. doi:10.1016/j.canlet.2010.08.009.

    Article  CAS  PubMed  Google Scholar 

  57. Patel JD, Bach PB, Kris MG. Lung cancer in US women: a contemporary epidemic. JAMA. 2004;291:1763–8. doi:10.1001/jama.291.14.1763.

    Article  CAS  PubMed  Google Scholar 

  58. Ramchandran K, Patel JD. Sex differences in susceptibility to carcinogens. Semin Oncol. 2009;36:516–23. doi:10.1053/j.seminoncol.2009.09.005.

    Article  CAS  PubMed  Google Scholar 

  59. Belani CP, Marts S, Schiller J, Socinski MA. Women and lung cancer: epidemiology, tumor biology, and emerging trends in clinical research. Lung Cancer. 2007;55:15–23. doi:10.1016/j.lungcan.2006.09.008.

    Article  PubMed  Google Scholar 

  60. Donington JS, Le QT, Wakelee HA. Lung cancer in women: exploring sex differences in susceptibility, biology, and therapeutic response. Clin Lung Cancer. 2006;8:22–9. doi:10.3816/CLC.2006.n.029.

    Article  PubMed  Google Scholar 

  61. Harichand-Herdt S, Ramalingam SS. Gender-associated differences in lung cancer: clinical characteristics and treatment outcomes in women. Semin Oncol. 2009;36:572–80. doi:10.1053/j.seminoncol.2009.10.007.

    Article  CAS  PubMed  Google Scholar 

  62. Donington JS, Colson YL. Sex and gender differences in non-small cell lung cancer. Semin Thorac Cardiovasc Surg. 2011;23:137–45. doi:10.1053/j.semtcvs.2011.07.001.

    Article  PubMed  Google Scholar 

  63. Pauk N, Kubik A, Zatloukal P, Krepela E. Lung cancer in women. Lung Cancer. 2005;48:1–9. doi:10.1016/j.lungcan.2004.10.009.

    Article  PubMed  Google Scholar 

  64. Planchard D, Loriot Y, Goubar A, Commo F, Soria JC. Differential expression of biomarkers in men and women. Semin Oncol. 2009;36:553–65. doi:10.1053/j.seminoncol.2009.09.004.

    Article  CAS  PubMed  Google Scholar 

  65. Henschke CI, Miettinen OS. Women’s susceptibility to tobacco carcinogens. Lung Cancer. 2004;43:1–5.

    Article  PubMed  Google Scholar 

  66. Zang EA, Wynder EL. Differences in lung cancer risk between men and women: examination of the evidence. J Natl Cancer Inst. 1996;88:183–92.

    Article  CAS  PubMed  Google Scholar 

  67. Asomaning K, et al. Second hand smoke, age of exposure and lung cancer risk. Lung Cancer. 2008;61:13–20. doi:10.1016/j.lungcan.2007.11.013.

    Article  PubMed  PubMed Central  Google Scholar 

  68. Clement-Duchene C, et al. Characteristics of never smoker lung cancer including environmental and occupational risk factors. Lung Cancer. 2010;67:144–50. doi:10.1016/j.lungcan.2009.04.005.

    Article  PubMed  Google Scholar 

  69. Thomas L, Doyle LA, Edelman MJ. Lung cancer in women: emerging differences in epidemiology, biology, and therapy. Chest. 2005;128:370–81. doi:10.1378/chest.128.1.370.

    Article  PubMed  Google Scholar 

  70. Fu JB, Kau TY, Severson RK, Kalemkerian GP. Lung cancer in women: analysis of the national Surveillance, Epidemiology, and End Results database. Chest. 2005;127:768–77. doi:10.1378/chest.127.3.768.

    Article  PubMed  Google Scholar 

  71. Hsu LH, et al. Sex-associated differences in non-small cell lung cancer in the new era: is gender an independent prognostic factor? Lung Cancer. 2009;66:262–7. doi:10.1016/j.lungcan.2009.01.020.

    Article  PubMed  Google Scholar 

  72. Bronte G, et al. Driver mutations and differential sensitivity to targeted therapies: a new approach to the treatment of lung adenocarcinoma. Cancer Treat Rev. 2010;36 Suppl 3:S21–9. doi:10.1016/S0305-7372(10)70016-5.

    Article  CAS  PubMed  Google Scholar 

  73. Li YJ, Tsai YC, Chen YC, Christiani DC. Human papilloma virus and female lung adenocarcinoma. Semin Oncol. 2009;36:542–52. doi:10.1053/j.seminoncol.2009.10.002.

    Article  PubMed  CAS  Google Scholar 

  74. Gatzemeier U, et al. Randomized phase II trial of gemcitabine-cisplatin with or without trastuzumab in HER2-positive non-small-cell lung cancer. Ann Oncol. 2004;15:19–27.

    Article  CAS  PubMed  Google Scholar 

  75. Chlebowski RT, et al. Oestrogen plus progestin and lung cancer in postmenopausal women (Women’s Health Initiative trial): a post-hoc analysis of a randomised controlled trial. Lancet. 2009;374:1243–51. doi:10.1016/S0140-6736(09)61526-9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  76. Ganti AK, Sahmoun AE, Panwalkar AW, Tendulkar KK, Potti A. Hormone replacement therapy is associated with decreased survival in women with lung cancer. J Clin Oncol. 2006;24:59–63. doi:10.1200/JCO.2005.02.9827.

    Article  CAS  PubMed  Google Scholar 

  77. Siegfried JM, Hershberger PA, Stabile LP. Estrogen receptor signaling in lung cancer. Semin Oncol. 2009;36:524–31. doi:10.1053/j.seminoncol.2009.10.004.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  78. Bouchardy C, et al. Lung cancer mortality risk among breast cancer patients treated with anti-estrogens. Cancer. 2011;117:1288–95. doi:10.1002/cncr.25638.

    Article  PubMed  Google Scholar 

  79. Nose N, Uramoto H, Iwata T, Hanagiri T, Yasumoto K. Expression of estrogen receptor beta predicts a clinical response and longer progression-free survival after treatment with EGFR-TKI for adenocarcinoma of the lung. Lung Cancer. 2011;71:350–5. doi:10.1016/j.lungcan.2010.06.009.

    Article  PubMed  Google Scholar 

  80. Stabile LP, et al. Combined targeting of the estrogen receptor and the epidermal growth factor receptor in non-small cell lung cancer shows enhanced antiproliferative effects. Cancer Res. 2005;65:1459–70. doi:10.1158/0008-5472.CAN-04-1872.

    Article  CAS  PubMed  Google Scholar 

  81. Traynor AM, et al. Pilot study of gefitinib and fulvestrant in the treatment of post-menopausal women with advanced non-small cell lung cancer. Lung Cancer. 2009;64:51–9. doi:10.1016/j.lungcan.2008.07.002.

    Article  PubMed  Google Scholar 

  82. Lord RV, et al. Low ERCC1 expression correlates with prolonged survival after cisplatin plus gemcitabine chemotherapy in non-small cell lung cancer. Clin Cancer Res. 2002;8:2286–91.

    CAS  PubMed  Google Scholar 

  83. Mok TS, et al. Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma. N Engl J Med. 2009;361:947–57. doi:10.1056/NEJMoa0810699.

    Article  CAS  PubMed  Google Scholar 

  84. Maemondo M, et al. Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR. N Engl J Med. 2010;362:2380–8. doi:10.1056/NEJMoa0909530.

    Article  CAS  PubMed  Google Scholar 

  85. Nelson HH, et al. Implications and prognostic value of K-ras mutation for early-stage lung cancer in women. J Natl Cancer Inst. 1999;91:2032–8.

    Article  CAS  PubMed  Google Scholar 

  86. Boehmer U, Miao X, Ozonoff A. Cancer survivorship and sexual orientation. Cancer. 2011;117:3796–804. doi:10.1002/cncr.25950.

    Article  PubMed  Google Scholar 

  87. Pizacani BA, et al. Smoking-related knowledge, attitudes and behaviors in the lesbian, gay and bisexual community: a population-based study from the U.S. Pacific Northwest. Prev Med. 2009;48:555–61. doi:10.1016/j.ypmed.2009.03.013.

    Article  PubMed  Google Scholar 

  88. Bonvicini KA, Perlin MJ. The same but different: clinician-patient communication with gay and lesbian patients. Patient Educ Couns. 2003;51:115–22.

    Article  PubMed  Google Scholar 

  89. Wallick MM, Cambre KM, Townsend MH. How the topic of homosexuality is taught at U.S. medical schools. Acad Med. 1992;67:601–3.

    Article  CAS  PubMed  Google Scholar 

  90. Ryan H, Wortley PM, Easton A, Pederson L, Greenwood G. Smoking among lesbians, gays, and bisexuals: a review of the literature. Am J Prev Med. 2001;21:142–9.

    Article  CAS  PubMed  Google Scholar 

  91. Lee JG, Griffin GK, Melvin CL. Tobacco use among sexual minorities in the USA, 1987 to May 2007: a systematic review. Tob Control. 2009;18:275–82. doi:10.1136/tc.2008.028241.

    Article  CAS  PubMed  Google Scholar 

  92. Weinmann M, Jeremic B, Toomes H, Friedel G, Bamberg M. Treatment of lung cancer in the elderly. Part I: non-small cell lung cancer. Lung Cancer. 2003;39:233–53.

    Article  PubMed  Google Scholar 

  93. Gridelli C, Langer C, Maione P, Rossi A, Schild SE. Lung cancer in the elderly. J Clin Oncol. 2007;25:1898–907. doi:10.1200/JCO.2006.10.3085.

    Article  PubMed  Google Scholar 

  94. Pallis AG, Scarci M. Are we treating enough elderly patients with early stage non-small cell lung cancer? Lung Cancer. 2011;74:149–54. doi:10.1016/j.lungcan.2011.05.025.

    Article  CAS  PubMed  Google Scholar 

  95. Quoix E, Westeel V, Zalcman G, Milleron B. Chemotherapy in elderly patients with advanced non-small cell lung cancer. Lung Cancer. 2011;74:364–8. doi:10.1016/j.lungcan.2011.06.006.

    Article  PubMed  Google Scholar 

  96. Sogaard M, Thomsen RW, Bossen KS, Sorensen HT, Norgaard M. The impact of comorbidity on cancer survival: a review. Clin Epidemiol. 2013;5:3–29. doi:10.2147/CLEP.S47150.

    Article  PubMed  PubMed Central  Google Scholar 

  97. Kumar A, Soares HP, Balducci L, Djulbegovic B, National Cancer Institute. Treatment tolerance and efficacy in geriatric oncology: a systematic review of phase III randomized trials conducted by five National Cancer Institute-sponsored cooperative groups. J Clin Oncol. 2007;25:1272–6. doi:10.1200/JCO.2006.09.2759.

    Article  CAS  PubMed  Google Scholar 

  98. Hutchins LF, Unger JM, Crowley JJ, Coltman Jr CA, Albain KS. Underrepresentation of patients 65 years of age or older in cancer-treatment trials. N Engl J Med. 1999;341:2061–7. doi:10.1056/NEJM199912303412706.

    Article  CAS  PubMed  Google Scholar 

  99. Lewis JH, et al. Participation of patients 65 years of age or older in cancer clinical trials. J Clin Oncol. 2003;21:1383–9.

    Article  PubMed  Google Scholar 

  100. Talarico L, Chen G, Pazdur R. Enrollment of elderly patients in clinical trials for cancer drug registration: a 7-year experience by the US Food and Drug Administration. J Clin Oncol. 2004;22:4626–31. doi:10.1200/JCO.2004.02.175.

    Article  PubMed  Google Scholar 

  101. Dale DC. Poor prognosis in elderly patients with cancer: the role of bias and undertreatment. J Support Oncol. 2003;1:11–7.

    PubMed  Google Scholar 

  102. Fentiman IS, et al. Cancer in the elderly: why so badly treated? Lancet. 1990;335:1020–2.

    Article  CAS  PubMed  Google Scholar 

  103. Rijke JM, et al. Influence of age, comorbidity and performance status on the choice of treatment for patients with non-small cell lung cancer; results of a population-based study. Lung Cancer. 2004;46:233–45. doi:10.1016/j.lungcan.2004.03.011.

    Article  PubMed  Google Scholar 

  104. Port JL, et al. Surgical resection for lung cancer in the octogenarian. Chest. 2004;126:733–8. doi:10.1378/chest.126.3.733.

    Article  PubMed  Google Scholar 

  105. Mery CM, et al. Similar long-term survival of elderly patients with non-small cell lung cancer treated with lobectomy or wedge resection within the surveillance, epidemiology, and end results database. Chest. 2005;128:237–45. doi:10.1378/chest.128.1.237.

    Article  PubMed  Google Scholar 

  106. Pallis AG, et al. EORTC Elderly Task Force and Lung Cancer Group and International Society for Geriatric Oncology (SIOG) experts’ opinion for the treatment of non-small-cell lung cancer in an elderly population. Ann Oncol. 2010;21:692–706. doi:10.1093/annonc/mdp360.

    Article  CAS  PubMed  Google Scholar 

  107. Lim E, et al. Guidelines on the radical management of patients with lung cancer. Thorax. 2010;65 Suppl 3:iii1–27. doi:10.1136/thx.2010.145938.

    Article  PubMed  Google Scholar 

  108. Kamiyoshihara M, Kawashima O, Ishikawa S, Morishita Y. Long-term results after pulmonary resection in elderly patients with non-small cell lung cancer. J Cardiovasc Surg. 2000;41:483–6.

    CAS  Google Scholar 

  109. Goodgame B, et al. Risk of recurrence of resected stage I non-small cell lung cancer in elderly patients as compared with younger patients. J Thorac Oncol. 2009;4:1370–4. doi:10.1097/JTO.0b013e3181b6bc1b.

    Article  PubMed  Google Scholar 

  110. Groth SS, et al. Conditional cancer-specific versus cardiovascular-specific survival after lobectomy for stage I non-small cell lung cancer. Ann Thorac Surg. 2010;90:375–82. doi:10.1016/j.athoracsur.2010.04.100.

    Article  PubMed  Google Scholar 

  111. Fruh M, et al. Pooled analysis of the effect of age on adjuvant cisplatin-based chemotherapy for completely resected non-small-cell lung cancer. J Clin Oncol. 2008;26:3573–81. doi:10.1200/JCO.2008.16.2727.

    Article  CAS  PubMed  Google Scholar 

  112. Dyszkiewicz W, Pawlak K, Gasiorowski L. Early post-pneumonectomy complications in the elderly. Eur J Cardiothorac Surg. 2000;17:246–50.

    Article  CAS  PubMed  Google Scholar 

  113. Meerbeeck JP, Damhuis RA, Vos de Wael ML. High postoperative risk after pneumonectomy in elderly patients with right-sided lung cancer. Eur Respir J. 2002;19:141–5.

    Article  PubMed  Google Scholar 

  114. Sullivan V, et al. Advanced age does not exclude lobectomy for non-small cell lung carcinoma. Chest. 2005;128:2671–6. doi:10.1378/chest.128.4.2671.

    Article  PubMed  Google Scholar 

  115. Balduyck B, Hendriks J, Lauwers P, Sardari Nia P, Van Schil P. Quality of life evolution after lung cancer surgery in septuagenarians: a prospective study. Eur J Cardiothorac Surg. 2009;35:1070–5; discussion 1075. doi:10.1016/j.ejcts.2009.01.050.

    Google Scholar 

  116. Okami J, et al. Pulmonary resection in patients aged 80 years or over with clinical stage I non-small cell lung cancer: prognostic factors for overall survival and risk factors for postoperative complications. J Thorac Oncol. 2009;4:1247–53. doi:10.1097/JTO.0b013e3181ae285d.

    Article  PubMed  Google Scholar 

  117. Pepe C, et al. Adjuvant vinorelbine and cisplatin in elderly patients: National Cancer Institute of Canada and Intergroup Study JBR.10. J Clin Oncol. 2007;25:1553–61. doi:10.1200/JCO.2006.09.5570.

    Article  CAS  PubMed  Google Scholar 

  118. Quoix E, et al. Carboplatin and weekly paclitaxel doublet chemotherapy compared with monotherapy in elderly patients with advanced non-small-cell lung cancer: IFCT-0501 randomised, phase 3 trial. Lancet. 2011;378:1079–88. doi:10.1016/S0140-6736(11)60780-0.

    Article  CAS  PubMed  Google Scholar 

  119. Tsukada H, et al. Randomized controlled trial comparing docetaxel (D)-cisplatin (P) combination with D alone in elderly patients (pts) with advanced non-small cell lung cancer (NSCLC): JCOG0207. J Clin Oncol. 2007;25:7629.

    Google Scholar 

  120. Shepherd FA, et al. Erlotinib in previously treated non-small-cell lung cancer. N Engl J Med. 2005;353:123–32. doi:10.1056/NEJMoa050753.

    Article  CAS  PubMed  Google Scholar 

  121. Jackman DM, et al. Phase II clinical trial of chemotherapy-naive patients > or = 70 years of age treated with erlotinib for advanced non-small-cell lung cancer. J Clin Oncol. 2007;25:760–6. doi:10.1200/JCO.2006.07.5754.

    Article  CAS  PubMed  Google Scholar 

  122. Haasbeek CJ, Lagerwaard FJ, Antonisse ME, Slotman BJ, Senan S. Stage I nonsmall cell lung cancer in patients aged > or =75 years: outcomes after stereotactic radiotherapy. Cancer. 2010;116:406–14. doi:10.1002/cncr.24759.

    Article  PubMed  Google Scholar 

  123. Vinod SK, Sidhom MA, Gabriel GS, Lee MT, Delaney GP. Why do some lung cancer patients receive no anticancer treatment? J Thorac Oncol. 2010;5:1025–32. doi:10.1097/JTO.0b013e3181da85e4.

    Article  PubMed  Google Scholar 

  124. Janssen-Heijnen ML, Schipper RM, Razenberg PP, Crommelin MA, Coebergh JW. Prevalence of co-morbidity in lung cancer patients and its relationship with treatment: a population-based study. Lung Cancer. 1998;21:105–13.

    Article  CAS  PubMed  Google Scholar 

  125. Gronberg BH, et al. Influence of comorbidity on survival, toxicity and health-related quality of life in patients with advanced non-small-cell lung cancer receiving platinum-doublet chemotherapy. Eur J Cancer. 2010;46:2225–34. doi:10.1016/j.ejca.2010.04.009.

    Article  PubMed  CAS  Google Scholar 

  126. Onega T, et al. Influence of NCI cancer center attendance on mortality in lung, breast, colorectal, and prostate cancer patients. Med Care Res Rev. 2009;66:542–60. doi:10.1177/1077558709335536.

    Article  PubMed  PubMed Central  Google Scholar 

  127. Rueth NM, et al. Surgical treatment of lung cancer: predicting postoperative morbidity in the elderly population. J Thorac Cardiovasc Surg. 2012;143:1314–23. doi:10.1016/j.jtcvs.2011.09.072.

    Article  PubMed  Google Scholar 

  128. Aboulafia DM. Decision making in non-AIDS-defining malignancies. Lancet Oncol. 2012;13:1172–3. doi:10.1016/S1470-2045(12)70520-X.

    Article  PubMed  Google Scholar 

  129. Bower M, et al. HIV-related lung cancer in the era of highly active antiretroviral therapy. AIDS. 2003;17:371–5. doi:10.1097/01.aids.0000050788.28043.cf.

    Article  PubMed  Google Scholar 

  130. Rengan R, Mitra N, Liao K, Armstrong K, Vachani A. Effect of HIV on survival in patients with non-small-cell lung cancer in the era of highly active antiretroviral therapy: a population-based study. Lancet Oncol. 2012;13:1203–9. doi:10.1016/S1470-2045(12)70466-7.

    Article  PubMed  Google Scholar 

  131. Suneja G, et al. Disparities in the treatment and outcomes of lung cancer among HIV-infected individuals. AIDS. 2013;27:459–68. doi:10.1097/QAD.0b013e32835ad56e.

    Article  PubMed  PubMed Central  Google Scholar 

  132. D’Jaen GA, et al. Human immunodeficiency virus-associated primary lung cancer in the era of highly active antiretroviral therapy: a multi-institutional collaboration. Clin Lung Cancer. 2010;11:396–404. doi:10.3816/CLC.2010.n.051.

    Article  PubMed  Google Scholar 

  133. Makinson A, Pujol JL, Le Moing V, Peyriere H, Reynes J. Interactions between cytotoxic chemotherapy and antiretroviral treatment in human immunodeficiency virus-infected patients with lung cancer. J Thorac Oncol. 2010;5:562–71. doi:10.1097/JTO.0b013e3181d3ccf2.

    Article  PubMed  Google Scholar 

  134. Sigel K, Wisnivesky J, Shahrir S, Brown S, Justice A, Kim J, Rodriguez-Barradas M, Akgun K, Rimland D, Soo Hoo G, Crothers K. Findings in asymptomatic HIV-infected patients undergoing chest computed tomography testing: implications for lung cancer screening. AIDS. 2014;28:1007–14, doi:10.1097/QAD.0000000000000189.

    Google Scholar 

  135. Hou W, Fu J, Ge Y, Du J, Hua S. Incidence and risk of lung cancer in HIV-infected patients. J Cancer Res Clin Oncol. 2013;139:1781–94. doi:10.1007/s00432-013-1477-2.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ching-Fei Chang M.D. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Chang, CF., Feigenbaum, G.S., Gould, M.K. (2016). Disparities in Lung Cancer Outcomes. In: Gerald, L., Berry, C. (eds) Health Disparities in Respiratory Medicine. Respiratory Medicine. Humana Press, Cham. https://doi.org/10.1007/978-3-319-23675-9_12

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-23675-9_12

  • Publisher Name: Humana Press, Cham

  • Print ISBN: 978-3-319-23674-2

  • Online ISBN: 978-3-319-23675-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics